Jodi Summers Holtrop Selected Research

4-nitro-3-dimethylaminopropiophenone

6/2020	Enhanced Enrollment in the National Diabetes Prevention Program to Increase Engagement and Weight Loss for the Underserved: Protocol for a Randomized Controlled Trial.
1/2019	Presessions to the National Diabetes Prevention Program May be a Promising Strategy to Improve Attendance and Weight Loss Outcomes.
11/2018	Effects of physical activity goal attainment on engagement and outcomes in the National Diabetes Prevention Program.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jodi Summers Holtrop Research Topics

Disease

5	Weight Loss (Weight Reduction) 01/2021 - 01/2016
2	Opioid-Related Disorders (Opiate Addiction) 01/2022 - 01/2022
2	Hypotension (Low Blood Pressure) 10/2017 - 01/2016
1	Chronic Pain 01/2022
1	Acute Pain 01/2022
1	Obesity 01/2021
1	Type 2 Diabetes Mellitus (MODY) 06/2020
1	Pain (Aches) 01/2019
1	Chronic Disease (Chronic Diseases) 01/2018
1	Acute Coronary Syndrome 09/2008

Drug/Important Bio-Agent (IBA)

3	Buprenorphine (Subutex)FDA LinkGeneric 01/2022 - 01/2022
3	4-nitro-3-dimethylaminopropiophenoneIBA 06/2020 - 11/2018
2	Opioid Analgesics (Opioids)IBA 01/2022 - 01/2019
2	Lipoproteins (Lipoprotein)IBA 10/2017 - 01/2016
1	SolutionsIBA 01/2022
1	Hemoglobins (Hemoglobin)IBA 01/2016
1	oxidized low density lipoproteinIBA 01/2016

Therapy/Procedure

1	Obesity Management 01/2021
1	Therapeutics 01/2021
1	Transitional Care 01/2018
1	Secondary Prevention 09/2008